| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000027855 |
| Receipt No. | R000031908 |
| Official scientific title of the study | relation between xanthine oxidoreductase and coronary plaque or endotherial function |
| Date of disclosure of the study information | 2017/06/26 |
| Last modified on | 2017/06/21 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | relation between xanthine oxidoreductase and coronary plaque or endotherial function | |
| Title of the study (Brief title) | relation between xanthine oxidoreductase and coronary plaque or endotherial function | |
| Region |
|
|
| Condition | ||
| Condition | coronary artery disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluating between xanthine oxidoreductase reactivity and coronary plaque or endothelial function |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Relation between xanthine oxidoreductase reactivity and coronary lipid plaque with NIRS-IVUS |
| Key secondary outcomes | 1. Relation between xanthine oxidoreductase reactivity and endothelial function with Endo-PAT
2. Distribution of xanthine oxidoreductase reactivity in coronary artery disease 3. Relation between xanthine oxidoreductase reactivity and uric acid 4. Relation between xanthine oxidoreductase reactivity and coronary plaque volume 5. Relation between purine bodies (hypoxanthine, xanthine) and coronary lipid plaque 6. Relation between purine bodies (hypoxanthine, xanthine) and endothelial function 7. Relation between uric acid and coronary plaque or endothelial function |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Diagnosis | ||
| Type of intervention |
|
||
| Interventions/Control_1 | 1. blood test
2. intravascular ultrasonography 3. endothelial function test |
||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patient who will undergo percutaneous coronary intervention with NIRS-IVUS in our hospital | |||
| Key exclusion criteria | 1. patients undergoing hemodialysis
2. patients taking inhibitor of xanthine oxidoreductase 3. patients who are not eligible by the investigators |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshio Kobayashi |
| Organization | Chiba University Hospital |
| Division name | Department of Cardiovascular Medicine |
| Address | 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan |
| TEL | 043-222-7171 |
| yoshio.kobayashi@wonder.ocn.ne.jp | |
| Public contact | |
| Name of contact person | Yuichi Saito |
| Organization | Chiba University Hospital |
| Division name | Department of Cardiovascular Medicine |
| Address | 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan |
| TEL | 043-222-7171 |
| Homepage URL | |
| policemaccho@yahoo.co.jp | |
| Sponsor | |
| Institute | Chiba University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031908 |